Aptevo Therapeutics Raises $3 Million in Gross Proceeds From Warrant Exercise

• Aptevo Therapeutics closed an existing common warrants exercise raising approximately $3 million in gross proceeds before placement agent fees and expenses.
• Holders agreed to exercise existing common warrants for up to 2,777,778 shares at a reduced exercise price of $1.08 per share.
• In exchange, new unregistered common stock purchase warrants will cover up to 13,888,890 shares at an exercise price of $1.08 per share.
• The new warrants become exercisable upon required stockholder approval; they expire five years after their initial exercise date.
• A planned SEC registration statement will cover resale of common stock issuable upon exercise of the new warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.